Shizhe Li
Shenyang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Correction: ARHGAP44-mediated regulation of the p53/C-myc/Cyclin D1 pathway in modulating the malignant biological behavior of osteosarcoma cells.
Journal: Journal of orthopaedic surgery and research
Published: December 17, 2023
ARHGAP44-mediated regulation of the p53/C-myc/Cyclin D1 pathway in modulating the malignant biological behavior of osteosarcoma cells.
Journal: Journal of orthopaedic surgery and research
Published: October 15, 2023
Current status and future challenges of CAR-T cell therapy for osteosarcoma.
Journal: Frontiers in immunology
Published: September 08, 2023
Current treatment and novel insights regarding ROS1-targeted therapy in malignant tumors.
Journal: Cancer medicine
Published: May 20, 2023
PROTACs: Novel tools for improving immunotherapy in cancer.
Journal: Cancer letters
Published: January 25, 2023
Targeted therapy for osteosarcoma: a review.
Journal: Journal of cancer research and clinical oncology
Published: October 27, 2022
The role of protein arginine N-methyltransferases in inflammation.
Journal: Seminars in cell & developmental biology
Published: August 13, 2022
Targeting matrix metalloproteinases by E3 ubiquitin ligases as a way to regulate the tumor microenvironment for cancer therapy.
Journal: Seminars in cancer biology
Published: May 05, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026